首页 › 基金 › Spruce Street Capital LP › PCVX
Spruce Street Capital LP 对 PCVX 的持仓历史
VAXCYTE INC · 医疗保健
Spruce Street Capital LP 在 Q3 2026 的 13F 申报中披露持有 PCVX(VAXCYTE INC)306,047 股,市值约 US$17.4M,约占其申报组合的 2.77%,在其申报持仓中市值排名第 11 位。 Spruce Street Capital LP 最近 4 个申报季度中有 4 个季度披露了 PCVX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Spruce Street Capital LP 对 PCVX 的持仓演变
Spruce Street Capital LP 于 Q4 2025 首次披露 PCVX 持仓:400,360 股(约 US$18.5M)。 在 4 次申报中,Spruce Street Capital LP 1 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 306,047 股、市值约 US$17.4M。 持仓曾出现大幅变动:Q1 2026 减持约 39% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 400.36K | $18.47M | 新进 |
| Q1 2026 | 245.71K | $14.28M | 减持 |
| Q2 2026 | 306.05K | $17.79M | 增持 |
| Q3 2026 | 306.05K | $17.41M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 PCVX 与 13F 数据
PCVX(VAXCYTE INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 PCVX,申报仓位最大的包括:Jupiter Topco LLC (US$1.04B), 骏利亨德森集团 (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 PCVX 的基金
- Jupiter Topco LLC 17.97M 股 · $1.04B · Q2 2026
- 骏利亨德森集团 16.58M 股 · $960.23M · Q1 2026
- T. Rowe Price Investment Management, Inc. 12.21M 股 · $709.62M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 11.47M 股 · $667.02M · Q2 2026
- Deep Track Capital, LP 4.30M 股 · $249.96M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 3.28M 股 · $186.60M · Q3 2026
- Kynam Capital Management, LP 2.92M 股 · $169.88M · Q2 2026
- Caligan Partners LP 2.19M 股 · $127.23M · Q2 2026
- Paradigm Biocapital Advisors LP 2.13M 股 · $123.69M · Q2 2026
- Bellevue Group AG 1.97M 股 · $114.63M · Q2 2026
- Maverick 资本 1.61M 股 · $93.78M · Q2 2026
- MAVERICK CAPITAL LTD 1.61M 股 · $93.78M · Q2 2026
更多关于 Spruce Street Capital LP
常见问题
How long has Spruce Street Capital LP held PCVX?
Spruce Street Capital LP has disclosed PCVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Spruce Street Capital LP's current position in PCVX?
As of Q3 2026, Spruce Street Capital LP holds 306.05K shares of PCVX (VAXCYTE INC), valued at $17.41M, representing 2.77% of its reported portfolio and ranking #11.
Has Spruce Street Capital LP been buying or selling PCVX?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in PCVX.
Which other funds hold PCVX?
Other major institutional holders of PCVX include Jupiter Topco LLC, 骏利亨德森集团, T. Rowe Price Investment Management, Inc., among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.